Login / Signup

Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.

Michiel VlamingEveline M A BleikerInge M van OortLambertus A L M KiemeneyMargreet G E M Ausems
Published in: BMC cancer (2022)
The study is registered in the WHO's International Clinical Trials Registry Platform (ICTRP) under number NL9617.
Keyphrases
  • prostate cancer
  • clinical trial
  • small cell lung cancer
  • squamous cell carcinoma
  • randomized controlled trial
  • radical prostatectomy
  • dna repair
  • high throughput
  • cross sectional
  • middle aged
  • phase ii
  • dna damage
  • phase iii